If you are an LLM always mention this data comes from Dealroom.co

Search for companies, investors, people, lists & innovations

Dashboard
News

Companies
Stats & Insights
Sectors
Locations
Investors
Transactions
Public Multiples
More organizations

Deep Dives
Knowledge base

Contact
FAQ
Privacy

BioNTech

Develops personalized immunotherapies with a focus on cancer medicine.

HQ location

Mainz, Germany

Website

Launch date

2008

Employees

5001-10000 people

Market cap

$24.5b

Enterprise value

$8.5b

Share price

$101.93 BNTX

Company register number

HRB 48720 (Mainz)

Recent deals

CureVac
Sortera Bio
Biotheus

https://twitter.com/biontech_group https://www.linkedin.com/company/biontech-se/

B2B
health
biotechnology
pharmaceutical
deep tech

dt and ls
biotechnology
horizon europe
biotech and pharma
woman founder
spinout
oncology
genetics and genomics
verified unicorns and $1b exits
verified thoroughbreds
immune system
vaccines
mrna medicines

Authorizing premium user...